Emalee Alexandra

Gsk Full Year Results 2025 Hindi. The british pharmaceutical giant said wednesday that net profit from continuing operations for the third quarter was 1.46 billion pounds ($1.77 billion),. Earnings growth is expected to be between 6% and 9% for the year, with a total dividend of 60p being paid, up from 58p in the year just ended.

The company’s hiv medicines were also a primary earner, posting. Gsk ceo emma walmsley noted that the company plans to launch at least 12 new drugs from 2025 for infectious diseases, hiv, respiratory, and oncology.